or Try an Advanced Search...

    Rare Diseases Stocks List

    Symbol Grade Name % Change
    NGNE D Neurogene, Inc. 2.94
    DSGN D Design Therapeutics, Inc. -1.66
    ALDX D Aldeyra Therapeutics, Inc. 2.42
    RARE C Ultragenyx Pharmaceutical Inc. -1.43
    TAK C Takeda Pharmaceutical Company Limited -0.75
    ABEO C Abeona Therapeutics Inc. -0.67
    KROS C Keros Therapeutics, Inc. -0.76
    PULM C Pulmatrix, Inc. 5.42
    WVE C WAVE Life Sciences Ltd. 3.37
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Biotechnology Biopharmaceutical Medical Genetics Organ Systems Acid Anemia Dysfunction Gene Therapy Genetic Engineering Genodermatoses Hematology Life Sciences Medicine Molecule Product Pharmacy Syndromes Adeno Associated Virus Arcturus Therapeutics Ataxia Autoimmune Disease

    Related ETFs - A few ETFs which own one or more of the above listed Rare Diseases stocks.

    Symbol Grade Name Weight
    SBIO C ALPS Medical Breakthroughs ETF 4.54
    PPH D Market Vectors Pharmaceutical ETF 4.27
    HELX D Franklin Genomic Advancements ETF 4.27
    DIVY A Sound Equity Income ETF 3.61
    VIRS A Pacer BioThreat Strategy ETF 2.96
    View all Rare Diseases ETFs...
    Compare ETFs
    Compare HELX to DIVY Compare SBIO to PPH Compare SBIO to VIRS

        Rare Diseases Stocks Recent News

        Date Stock Title
        Sep 27 TAK How Many Stocks Should You Own?
        Sep 27 WVE Wave put on J.P. Morgan Positive Catalyst Watch ahead of data readout
        Sep 27 TAK Tempus AI expands oncology collaboration with Takeda
        Sep 26 WVE Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More
        Sep 26 TAK Tempus announces expansion of collaboration with Takeda
        Sep 26 RARE Ultragenyx Announces Upcoming Setrusumab (UX143) Presentations at the ASBMR 2024 Annual Meeting
        Sep 26 DSGN Pleasing Signs As A Number Of Insiders Buy Design Therapeutics Stock
        Sep 26 WVE Wave Life Sciences prices $200M stock offering
        Sep 26 WVE Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
        Sep 25 WVE General Motors To $42? Here Are 10 Top Analyst Forecasts For Wednesday
        Sep 25 WVE WVE Stock Soars on Upbeat Efficacy Data From Muscle Disease Study
        Sep 25 WVE Wave’s stock swells as it eyes approval following Phase II DMD victory
        Sep 24 WVE Wave Life Sciences proposes secondary offering of ordinary shares, pre-funded warrants
        Sep 24 WVE Sector Update: Health Care Stocks Mixed Late Afternoon
        Sep 24 WVE Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
        Sep 24 WVE Wave Life Sciences: Spiking On Strong DMD Data, But Not Fully De-Risked Yet
        Sep 24 WVE Top Midday Gainers
        Sep 24 WVE Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug
        Sep 24 WVE Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug
        Sep 24 TAK The Zacks Analyst Blog Highlights Takeda Pharma, Naspers and Packaging Corp. of America
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Biopharmaceutical Biotechnology Medicine Cancer Clinical Medicine Clinical Research Dermatology Disease Drugs Epidermolysis Bullosa Genodermatoses Inflammation Organ Systems Acid Acquired Hemolytic Anemia Acute Pain Aesthetics Amphetamine Angioedema Antacid
        Rare Diseases

        Rare diseases are medical conditions that affect a small percentage of the population. They are often genetic, chronic, and progressive, and can cause significant physical and mental disability. There are over 7,000 rare diseases, and many of them have no known cure.

        Browse All Tags